136 related articles for article (PubMed ID: 28193179)
1. Gene expression profiles associated with cigarette smoking and moist snuff consumption.
Arimilli S; Madahian B; Chen P; Marano K; Prasad GL
BMC Genomics; 2017 Feb; 18(1):156. PubMed ID: 28193179
[TBL] [Abstract][Full Text] [Related]
2. Global methylation profiles in buccal cells of long-term smokers and moist snuff consumers.
Jessen WJ; Borgerding MF; Prasad GL
Biomarkers; 2018 Nov; 23(7):625-639. PubMed ID: 29771158
[TBL] [Abstract][Full Text] [Related]
3. Pathway Analysis of Global Metabolomic Profiles Identified Enrichment of Caffeine, Energy, and Arginine Metabolism in Smokers but Not Moist Snuff Consumers.
Liu G; Lee DP; Schmidt E; Prasad GL
Bioinform Biol Insights; 2019; 13():1177932219882961. PubMed ID: 31666793
[TBL] [Abstract][Full Text] [Related]
4. Differences in biomarkers of inflammation and immune responses in chronic smokers and moist snuff users.
Tran QT; Arimilli S; Scott E; Chen P; Prasad GL
Cytokine; 2021 Jan; 137():155299. PubMed ID: 33011400
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study of biomarkers of exposure and effect in smokers and moist snuff consumers.
Prasad GL; Jones BA; Chen P; Gregg EO
Clin Chem Lab Med; 2016 Apr; 54(4):633-42. PubMed ID: 26495926
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory profile analysis reveals differences in cytokine expression between smokers, moist snuff users, and dual users compared to non-tobacco consumers.
Sgambato JA; Jones BA; Caraway JW; Prasad GL
Cytokine; 2018 Jul; 107():43-51. PubMed ID: 29217402
[TBL] [Abstract][Full Text] [Related]
7. Study of cardiovascular disease biomarkers among tobacco consumers, part 1: biomarkers of exposure.
Campbell LR; Brown BG; Jones BA; Marano KM; Borgerding MF
Inhal Toxicol; 2015 Feb; 27(3):149-56. PubMed ID: 25787703
[TBL] [Abstract][Full Text] [Related]
8. Study of cardiovascular disease biomarkers among tobacco consumers. Part 3: evaluation and comparison with the US National Health and Nutrition Examination Survey.
Marano KM; Kathman SJ; Jones BA; Nordskog BK; Brown BG; Borgerding MF
Inhal Toxicol; 2015 Feb; 27(3):167-73. PubMed ID: 25787702
[TBL] [Abstract][Full Text] [Related]
9. Trends in annual sales and current use of cigarettes, cigars, roll-your-own tobacco, pipes, and smokeless tobacco among US adults, 2002-2012.
Agaku IT; Alpert HR
Tob Control; 2016 Jul; 25(4):451-7. PubMed ID: 25899447
[TBL] [Abstract][Full Text] [Related]
10. Cigarette smoking, oral moist snuff use and glucose intolerance.
Persson PG; Carlsson S; Svanström L; Ostenson CG; Efendic S; Grill V
J Intern Med; 2000 Aug; 248(2):103-10. PubMed ID: 10947888
[TBL] [Abstract][Full Text] [Related]
11. Snuffing out cigarette sales and the smoking deaths epidemic.
Laugesen M
N Z Med J; 2007 Jun; 120(1256):U2587. PubMed ID: 17589555
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic perspectives on smokeless tobacco marketing and population harm.
Tomar SL
Am J Prev Med; 2007 Dec; 33(6 Suppl):S387-97. PubMed ID: 18021914
[TBL] [Abstract][Full Text] [Related]
13. Distinct gene expression changes in human peripheral blood mononuclear cells treated with different tobacco product preparations.
Arimilli S; Makena P; Liu G; Prasad GL
Toxicol In Vitro; 2019 Jun; 57():117-125. PubMed ID: 30776502
[TBL] [Abstract][Full Text] [Related]
14. Smoking, use of moist snuff, and risk of chronic inflammatory diseases.
Carlens C; Hergens MP; Grunewald J; Ekbom A; Eklund A; Höglund CO; Askling J
Am J Respir Crit Care Med; 2010 Jun; 181(11):1217-22. PubMed ID: 20203245
[TBL] [Abstract][Full Text] [Related]
15. Study of cardiovascular disease biomarkers among tobacco consumers, part 2: biomarkers of biological effect.
Nordskog BK; Brown BG; Marano KM; Campell LR; Jones BA; Borgerding MF
Inhal Toxicol; 2015 Feb; 27(3):157-66. PubMed ID: 25787701
[TBL] [Abstract][Full Text] [Related]
16. Consumption of Combustible and Smokeless Tobacco - United States, 2000-2015.
Wang TW; Kenemer B; Tynan MA; Singh T; King B
MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(48):1357-1363. PubMed ID: 27932780
[TBL] [Abstract][Full Text] [Related]
17. Smokeless tobacco (moist snuff) use and the risk of developing rheumatoid arthritis: results from a case-control study.
Jiang X; Alfredsson L; Klareskog L; Bengtsson C
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1582-6. PubMed ID: 24719251
[TBL] [Abstract][Full Text] [Related]
18. Relationship of maternal snuff use and cigarette smoking with neonatal apnea.
Gunnerbeck A; Wikström AK; Bonamy AK; Wickström R; Cnattingius S
Pediatrics; 2011 Sep; 128(3):503-9. PubMed ID: 21873701
[TBL] [Abstract][Full Text] [Related]
19. Free nicotine content and strategic marketing of moist snuff tobacco products in the United States: 2000-2006.
Alpert HR; Koh H; Connolly GN
Tob Control; 2008 Oct; 17(5):332-8. PubMed ID: 18669556
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
